Old Web
English
Sign In
Acemap
>
Paper
>
Dapagliflozin: A Newly Approved SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
Dapagliflozin: A Newly Approved SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
2014
Ann Marie Ruhe
Rachel Muhlenkamp
Austin Brown
Emily Blum
Sandra L Hrometz
Keywords:
Type 2 Diabetes Mellitus
Pharmacology
SGLT2 Inhibitor
Medicine
Dapagliflozin
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]